ASPEN AEROGELS INC (ASPN) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does ASPEN AEROGELS INC Do?
Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts. ASPEN AEROGELS INC (ASPN) is classified as a micro-cap stock in the Consumer Staples sector, specifically within the Wholesale industry. The company is led by CEO Donald R. Young and employs approximately 420 people, headquartered in NORTHBOROUGH, Massachusetts. With a market capitalization of $287M, ASPN is one of the notable companies in the Consumer Staples sector.
ASPEN AEROGELS INC (ASPN) Stock Rating — Reduce (April 2026)
As of April 2026, ASPEN AEROGELS INC receives a Reduce rating with a composite score of 26.3/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.ASPN ranks #3,417 out of 4,446 stocks in our coverage universe. Within the Consumer Staples sector, ASPEN AEROGELS INC ranks #147 of 180 stocks, placing it in the lower half of its Consumer Staples peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
ASPN Stock Price and 52-Week Range
ASPEN AEROGELS INC (ASPN) currently trades at $3.35. The stock lost $0.39 (10.4%) in the most recent trading session. The 52-week high for ASPN is $9.78, which means the stock is currently trading -65.7% from its annual peak. The 52-week low is $2.30, putting the stock 45.7% above its annual trough. Recent trading volume was 2.1M shares, reflecting moderate market activity.
Is ASPN Overvalued or Undervalued? — Valuation Analysis
ASPEN AEROGELS INC (ASPN) carries a value factor score of 10/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 1.30x, versus the sector average of 1.74x. The price-to-sales ratio is 0.88x, compared to 0.35x for the average Consumer Staples stock.
At current multiples, ASPEN AEROGELS INC trades at a premium to most Consumer Staples peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.
ASPEN AEROGELS INC Profitability — ROE, Margins, and Quality Score
ASPEN AEROGELS INC (ASPN) earns a quality factor score of 26/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -139.9%, compared to the Consumer Staples sector average of 7.7%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -81.0% versus the sector average of 3.1%.
On a margin basis, ASPEN AEROGELS INC reports gross margins of 32.9%, compared to 26.2% for the sector. The operating margin is -94.2% (sector: 2.9%). Net profit margin stands at -103.5%, versus 1.6% for the average Consumer Staples stock. Revenue growth is running at -38.0% on a trailing basis, compared to 3.1% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.
ASPN Debt, Balance Sheet, and Financial Health
ASPEN AEROGELS INC has a debt-to-equity ratio of 28.0%, compared to the Consumer Staples sector average of 72.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 3.90x, indicating strong short-term liquidity. Total debt on the balance sheet is $65M. Cash and equivalents stand at $151M.
ASPN has a beta of 1.50, meaning it is more volatile than the broader market — a $10,000 investment in ASPN would be expected to move 49.7% more than the S&P 500 on any given day. The stability factor score for ASPEN AEROGELS INC is 23/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.
ASPEN AEROGELS INC Revenue and Earnings History — Quarterly Trend
In TTM 2026, ASPEN AEROGELS INC reported revenue of $347M and earnings per share (EPS) of $-4.73. Net income for the quarter was $-330M. Gross margin was 32.9%. Operating income came in at $-290M.
In FY 2025, ASPEN AEROGELS INC reported revenue of $271M and earnings per share (EPS) of $-4.73. Net income for the quarter was $-390M. Gross margin was 17.0%. Revenue grew -40.1% year-over-year compared to FY 2024. Operating income came in at $-378M.
In Q3 2025, ASPEN AEROGELS INC reported revenue of $73M and earnings per share (EPS) of $-0.08. Net income for the quarter was $-6M. Gross margin was 28.5%. Revenue grew -37.8% year-over-year compared to Q3 2024. Operating income came in at $-3M.
In Q2 2025, ASPEN AEROGELS INC reported revenue of $78M and earnings per share (EPS) of $-0.11. Net income for the quarter was $-9M. Gross margin was 32.5%. Revenue grew -33.7% year-over-year compared to Q2 2024. Operating income came in at $-5M.
Over the past 8 quarters, ASPEN AEROGELS INC has demonstrated a growth trajectory, with revenue expanding from $118M to $347M. Investors analyzing ASPN stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
ASPN Dividend Yield and Income Analysis
ASPEN AEROGELS INC (ASPN) does not currently pay a dividend. This is common among smaller companies in the Wholesale industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Consumer Staples dividend stocks may want to explore other Consumer Staples stocks or use the stock screener to filter by dividend yield.
ASPN Momentum and Technical Analysis Profile
ASPEN AEROGELS INC (ASPN) has a momentum factor score of 24/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 39/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 48/100 reflects moderate short selling activity.
ASPN vs Competitors — Consumer Staples Sector Ranking and Peer Comparison
Within the Consumer Staples sector, ASPEN AEROGELS INC (ASPN) ranks #147 out of 180 stocks based on the Blank Capital composite score. This places ASPN in the lower half of all Consumer Staples stocks in our coverage universe. Key competitors and sector peers include Ituran Location & Control Ltd. (ITRN) with a score of 60.3/100, DARLING INGREDIENTS INC. (DAR) with a score of 52.9/100, Bunge Global SA (BG) with a score of 53.0/100, SANFILIPPO JOHN B & SON INC (JBSS) with a score of 54.1/100, and Archer-Daniels-Midland Co (ADM) with a score of 52.2/100.
Comparing ASPN against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full ASPN vs S&P 500 (SPY) comparison to assess how ASPEN AEROGELS INC stacks up against the broader market across all factor dimensions.
ASPN Next Earnings Date
No upcoming earnings date has been announced for ASPEN AEROGELS INC (ASPN) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy ASPN? — Investment Thesis Summary
The quantitative profile for ASPEN AEROGELS INC suggests caution. The quality score of 26/100 flags below-average profitability. The value score of 10/100 indicates premium valuation. Momentum is weak at 24/100, a headwind for near-term performance. High volatility (stability score 23/100) increases portfolio risk.
In summary, ASPEN AEROGELS INC (ASPN) earns a Reduce rating with a composite score of 26.3/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on ASPN stock.
Related Resources for ASPN Investors
Explore more research and tools: ASPN vs S&P 500 comparison, top Consumer Staples stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare ASPN head-to-head with peers: ASPN vs ITRN, ASPN vs DAR, ASPN vs BG.